Mechanisms of resistance to the FLT3-tyrosine kinase inhibitor PKC412 in patients with AML Meeting Abstract


Authors: Heidel, F.; Breitenbuecher, F.; Kindler, T.; Solem, F. K.; Carius, B.; Thiede, H. M.; Cohen, P. S.; Roesel, J.; Estey, E. H.; Feldman, E.; Ehninger, G.; Schiller, G. J.; Klimek, V.; Nimer, S.; DeAngelo, D.; Giles, F.; Stone, R. M.; Huber, C.; Fischer, T.
Abstract Title: Mechanisms of resistance to the FLT3-tyrosine kinase inhibitor PKC412 in patients with AML
Meeting Title: 46th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 104
Issue: 11 Pt. 1
Meeting Dates: 2004 Dec 4-7
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2004-11-16
Start Page: 133A
Language: English
ACCESSION: WOS:000225127500457
PROVIDER: wos
PUBMED: 15562524
DOI: 10.1182/blood.V104.11.454.454
Notes: Meeting Abstract: 454 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Virginia Klimek
    147 Klimek
  2. Stephen D Nimer
    347 Nimer